Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study

NCT03336814 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT03336814
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03336814 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Early Association of Terlipressin and Norepinephrine During Septic Shock; the TerliNor Study
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Phase 4
Overall status
Unknown status
Start date
July 27, 2018
Completion date
June 1, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock